Preclinical Development of Novel Bifunctional Compounds for Parkinson's Disease (original) (raw)

Drug treatment of Parkinson’s disease

Freek van Muiswinkel

Biochemical Pharmacology, 2000

View PDFchevron_right

Development of new biocontrol agents for Parkinsonia

T. Heard

View PDFchevron_right

Diagnosis and treatment of Parkinson disease: molecules to medicine

Joseph Savitt

Journal of Clinical Investigation, 2006

View PDFchevron_right

Advances in Drug Development for Parkinson's Disease: Present Status

Harikrishna reddy

View PDFchevron_right

A comprehensive review on management of Parkinson’s disease, inclusive of drug discovery and pharmacological approaches

Abdel-Nasser El-Shorbagi

journal of applied pharmaceutical science, 2020

View PDFchevron_right

Emerging therapies in the pharmacological treatment of Parkinson's disease

Miri Nussbaum

Drugs, 2002

View PDFchevron_right

Novel pharmacological targets for the treatment of Parkinson's disease

Graham Collingridge

Nature Reviews Drug Discovery, 2006

View PDFchevron_right

Multifunctional role of natural products for the treatment of Parkinson’s disease: At a glance

Shopnil Akash 181-29-059

Frontiers in Pharmacology

View PDFchevron_right

Advances in the treatment of Parkinson's disease

Neha Singh

Progress in Neurobiology, 2007

View PDFchevron_right

Therapeutic and Prophylactic Effect of some Agents on Experimental Induced Parkinson Disease Models Review

Sarvananda Letchuman

Article, 2021

View PDFchevron_right

Management of Parkinson׳s disease: Current and future pharmacotherapy

Neha Dahiya

European Journal of Pharmacology, 2015

View PDFchevron_right

Milestones in Parkinson's disease therapeutics

Olivier Rascol

Movement Disorders, 2011

View PDFchevron_right

Promising drug targets and associated therapeutic interventions in Parkinson's disease

Dr. Vivek K . Chaturvedi

Neural Regeneration Research

View PDFchevron_right

Meeting Commentary-"Parkinson's disease: From patient to product

John Wahlich

International journal of pharmaceutics, 2015

View PDFchevron_right

Current Approaches and Tools Used in Drug Development against Parkinson’s Disease

Dariusz Matosiuk

Biomolecules, 2021

View PDFchevron_right

Novel therapeutic strategies in Parkinson’s disease

László Vecsei

European Journal of Clinical Pharmacology, 2009

View PDFchevron_right

Pharmacotherapy for Parkinson's disease

Jack Chen

Pharmacotherapy, 2007

View PDFchevron_right

Current Pharmacotherapeutic Treatment Options in Parkinson’s Disease

Michael Rezak

Disease-a-Month, 2007

View PDFchevron_right

Recent advances in Parkinson disease

Pharmaceutical and Biological Evaluations

View PDFchevron_right

The Development of Treatment for Parkinson’s Disease

Dr.Harishankar yadav

Advances in Parkinson's Disease, 2015

View PDFchevron_right

Current and Potential Treatments of Parkinson's Disease

PREKSHA PATEL

View PDFchevron_right

Highly Potent Activity of (1 R ,2 R ,6 S )-3-Methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in Animal Models of Parkinson’s Disease

Konstantin Volcho

Journal of Medicinal Chemistry, 2011

View PDFchevron_right

Drug management of Parkinson's disease

Asha Kishore

Canadian Family Physician Medecin De Famille Canadien, 1996

View PDFchevron_right

A study of novel molecules for parkinson‘s disease treatment molecular mechanisms of neurodegenerative complexities and brain protection

N Krishna Chythanya N

IP Indian Journal of Neurosciences, 2020

View PDFchevron_right

Neuroprotective agents for clinical trials in Parkinson's disease: A systematic assessment

Diane DiEuliis

Neurology, 2004

View PDFchevron_right

Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s Symptoms

Dr Palanisamy Sivanandy

International Journal of Environmental Research and Public Health, 2021

View PDFchevron_right

Novel Therapies for Parkinsonian Syndromes–Recent Progress and Future Perspectives

Natalia Madetko

Frontiers in Molecular Neuroscience, 2021

View PDFchevron_right